BioMerieux SA (EURONEXT:BIM)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - BIM

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - BIM

  • Market Cap€14.912bn
  • SymbolEURONEXT:BIM
  • IndustryHealthcare
  • SectorDiagnostics & Research
  • Currency
  • ISINFR0013280286

Company Profile

BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (about 38% of sales), microbiology (about 32%), immunoassays (about 15%), and industrial applications (about 15%). Europe, the Middle East, and Africa accounts for the largest portion of the firm's revenue (38%), followed by North America (38%), Asia-Pacific (17%), and Latin America (7%). BioMerieux is headquartered in Marcy-l'Etoile, France.BioMerieux SA is a pharmaceutical company with business spread across the world. The firm designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination.

Latest BIM news

Currently there for this company. Visit our news hub for other news .